2018 International Congress Archives - Page 177 of 177

T lymphocytes in Parkinson’s disease pathogenesis and therapy: A systematic review

J. Baird, J. Quinn (Portland, OR, USA)
Tardive Myoclonus: A Case Report

S. Gazioglu, F. Civil Arslan, V. Altunayoglu Cakmak, M. Korucuk, M. Ozmenoglu (Trabzon, Turkey)
Targeted Next Generation Sequencing in Diagnosis of Dystonia Patients

J. Ma, X.H. Wan (Beijing, China)
Targeting GPi: DBS Treating Dystonia in a Patient with Wilson’s Disease

L. Sperry, X. Duan, F. Girgis, K. Denny, S. Farias, D. Kahn, V. Medici, L. Zhang, K. Shahlaie (Sacramento, CA, USA)
Task effects on lingual kinematics in dysarthric individuals with Parkinson’s disease: Insights from two cases

M. Wong (Hong Kong, Hong Kong)
Task-specific embouchure dystonia in a flutist

I. Bledsoe (San Francisco, CA, USA)
Tau and α-synuclein autoantibodies as potential biomarkers for Parkinson’s and Alzheimer’s diseases

A. Shalash, M. Salama, M. Makar, T. Roushdy, M. El-Balkimy (Cairo, Egypt)
Teed and primary cell longevity: Results from product surveillance registry

P. Konrad, G. Plotkin, S. Palfi, E. Cuny, J-P. Azulay, T. Witt, T. Theys, Y. Temel, G. Johnson, K. Bhatia, T. Weaver, M. Schiess, J. Krauss, S. Falowski (Nashville, TN, USA)
Tef polymorphism predicts the decline of sleep disturbances in Parkinson’s disease

P. Hua, W. Liu (Nanjing, China)
Telepsychiatry for Patients with Parkinson’s disease

M. Heiry, N. Galifianakis, J. Ostrem, A. Seritan (San Francisco, CA, USA)
Temporal discrimination threshold in musician’s dystonia – an endophenotype?

F. Borngräber, T. Paulus, J. Junker, S. Passmann, R. Reilly, M. Hutchinson, C. Klein, A. Kühn, E. Altenmüller, T. Bäumer, A. Schmidt (Berlin, Germany)
Temporal Discrimination Threshold is Associated with Multiple Regions of Resting-State Brain Activity in Musician’s Dystonia

F. Maguire, R. Reilly, K. Simonyan (Dublin, Ireland)
Temporal evolution of biomarkers from healthy ageing, isolated REM sleep behavior to early Parkinson’s disease

B. Mollenhauer, M-L. Muntean, J. Zimmermann, K. Focke, T. Wicke, J. Ebentheuer, M. Schaumburg, E. Lang, WH. Oertel, F. Sixel-Döring, C. Trenkwalder (Kassel, Germany)
Temporal Gait Parameters in Parkinson’s Disease: A Study Using PDlogger, A Quantitative Gait Measuring Device

N. Chia, J. Derrick, V. Mikos, S. Ng, A. Tay, S-C. Yen, K. Koh, D. Tan, K. Prakash, L. Tan, W.L. Au (Singapore, Singapore)
Tendency towards being a “Morning person” increases risk of Parkinson’s disease: evidence from Mendelian randomisation

A. Noyce, D. Kia, K. Heilbron, J. Jepson, G. Hemani, D. Hinds, D. Lawlor, G. Davey Smith, J. Hardy, A. Singleton, M. Nalls, N. Wood (London, United Kingdom)
Tetrahydroisoquinoline Molecule Identified in Traditional Ayurveda Medicine Modulates Inflammation in MPTP Mice

R. Banerjee, R. Paidi, P. Jaisankar, K. Mohanakumar, S. Biswas (Kolkata, India)
Thalamic deep brain stimulation of the ventral intermediate nucleus in patients with dystonic head tremor

M. Wolf, C. Blahak, A. Saryyeva, J. Runge, J. Krauss (Mannheim, Germany)
Thalamic Tremor Following Focused Ultrasound Thalamotomy for Essential Tremor

T. Osterholt, A. Fois, T. Popa, F. Vial Undurraga, S. Horovitz, M. Hallett, D. Haubenberger (Bethesda, MD, USA)
The “Second-Night” Effect: A Comparison of Sleep Behavior between the Sleep Laboratory and In-Home Settings

X. Cai, C. Dethridge, A. Chang, J. Bhangu, D. Karlin, T. Wager, F. Hameed, A. Steinman, D. Volfson, E. Pickering, K. Thomas (Cambridge, MA, USA)
The Adaptation of Card Games for Education in Movement Disorders

S. Schaefer, A. Vives Rodriguez (New Haven, CT, USA)
The Akt/mTOR/P70S6K/4EB-P1 signaling pathway is activated by metformin in a toxin-induced cellular model of Parkinson’s disease

P. Dharmasaroja, P. Chanthammachat (Bangkok, Thailand)
The analysis of cognitive impairment associated with Parkinson’s disease

Z. Mao, X. Xue (Hubei, China)
The anti-dyskinetic effect of the clinically-available 5-HT3 receptor antagonist granisetron in the 6-OHDA-lesioned rat model of Parkinson’s disease

C. Kwan, I. Frouni, D. Bedard, A. Hamadjida, P. Huot (Montreal, QC, Canada)
The Association between Infections and Parkinson Disease: A Systematic Review and Meta-analysis

M. Morra, S. Ghozy, E. Sakr, M. Elfaituri, M. Khattab, M. Mahmoud, S. Mehyar, M. Alhattab, A. Ahmed Ismail, M. Abdelmongy, M. Fahmy, E. Gharib, A. Hallab, N. Huy (Cairo, Egypt)
The Association Between Inhibitory Control and Freezing of Gait Severity in Parkinson’s Disease

E. Bayram, S. Banks, J. Longhurst, B. Bluett (Las Vegas, NV, USA)
The association between pain and physical activity in people with Parkinson’s Disease (PD)

H. Khalil, A. Al-Sharman, N. Alissa, K. El-Salem, D. Al-Shorafat (Irbid, Jordan)
The association of primary dystonia with tics – chance or new syndrome?

C. Del Gamba, A. Latorre, U. Bonuccelli, R. Ceravolo, K. Bhatia (London, United Kingdom)
The BeyoND study: Design and baseline characteristics of a study evaluating the long-term safety of ND0612 for motor fluctuations in Parkinson’s disease

W. Poewe, F. Stocchi, A. Espay, T. Rachmilewitz Minei, S. Oren, R. Case, K. Kieburtz, C. Olanow (Innsbruck, Austria)
The BlueSky Project: monitoring motor and non-motor characteristics of people with Parkinson’s disease in the laboratory, a simulated apartment, and home and community settings

K. Erb, J. Daneault, S. Amato, P. Bergethon, C. Demanuele, T. Kangarloo, S. Patel, V. Ramos, D. Volfson, P. Wacnik, H. Zhang, D. Karlin, H. Huggins, L. Soll, G. Costante, G. Vergara-Diaz, F. Parisi, J. Banghu, C. Brooks, C. Dethridge, A. Abrami, E. Bilal, V. Caravagio, S. Heisig, R. Norel, E. Pissadaki, J. Rice, B. Ho, K. Thomas, P. Bonato (Cambridge, MA, USA)
The Catalonian Multiple System Atrophy Registry (CMSAR): The motor features and their impact on disability status in MSA patients

A. Perez-Soriano, DM. Giraldo, J. Rios-Guillermo, E. Muñoz, Y. Compta, MJ. Marti, On-behalf-of-Catalonian-MSA-Registry (Barcelona, Spain)
The change of heart rate variability after subthalamic nucleus deep brain stimulation in patients with Parkinson’s disease: A Meta⁃analysis

X.Y. Luo, R. Ou, H.F. Shang (Chengdu, People’s Republic of China)
The change of SIRT1 and HIF-1 in MPTP treated mouse

X.X. Cui, S.Y. Dong, Y.J. Guo, W.J. Zhao, Y.C. Wu (Shanghai, China)
The characteristic of gait in progressive progressive supranuclear palsy

Y. Takamatsu, N. Matsuda, I. Aiba (Kyoto, Japan)
The Characteristics of Patients with Movement Disorders in a Diverse Inner-City Hospital

L. Nwabuobi, J. Agee, M. Ko, R. Gilbert (New York, NY, USA)
The clinical characteristics and cognitive features of mild cognitive impairment in Parkinson’s disease and analysis of relevant factors

K. Nie, Y. Gao, M. Mei, M. Guo, Z. Huang, L. Wang, J. Zhao, Y. Zhang, L. Wang (Guangzhou, China)
The Clinical Research of Parkinson’s Disease with Rapid Eye Movement Sleep Behavior Disorder

Y. Wang, Z. Liang (Dalian, China)
The clinical spectrum of motor stereotypies in progressive supranuclear palsy: An early, frequent and underestimated symptom

J. Pagonabarraga, A. Horta-Barba, I. Illan, I. Aracil, H. Bejr-Kasem, J. Pérez-Pérez, J. Marín-Lahoz, B. Pascual-Sedano, S. Martinez-Horta, J. Kulisevsky (Barcelona, Spain)
The clinical value of SPECT in identifying dystonic muscles of patients with cervical dystonia

L. Jin, L. Feng, I. Djibo, S. Chen, F. Teng, B. Li, H. Ma (Shanghai, China)
The combined effect of repetitive transcranial magnetic stimulation and treadmill training in people with Parkinson’s disease – A randomized controlled trial

C. Chung, M. Mak, M. AuYeung, Y. Chan, N. Cheung, V. Mok, M. Hallett (Hong Kong, Hong Kong)
The comparative clinical analysis of sleep patterns in patients with Amyotrophic Lateral Sclerosis and Parkinson’s disease

S. Shuang, Z. Liang (Dalian, China)
The comparison of the clinical characteristics and treatment outcomes between non-troublesome and troublesome hemifacial spasm in Thai patients

Y. Pitakpatapee, A. Suengtaworn, P. Soontrapa, P. Srivanitchapoom (Bangkok, Thailand)
The comparison of three brief cognitive tests for diagnosing mild cognitive impairment in newly diagnosed Parkinson’s disease

S. Kim, J. Jung, D. Seog (Busan, Republic of Korea)
The complementary relationship between zonisamide and istradefylline in treating patients with Parkinson’s disease

T. Kadowaki, M. Hamaguchi, H. Sakuramoto, T. Shiina, H. Fujita, K. Suzuki, K. Hirata (Mibu, Japan)
The correlation studies between cholinergic cognitive impairment of Parkinson’s disease and the cortex thickness of brain

Y. Zhang, B. Li (Guang Zhou, China)
The course of Parkinson’s disease in patients with impaired carbohydrate metabolism

F. Akhmedova, B. Shagazatova, D. Artikova, F. Mirxaydarova (Tashkent, Uzbekistan)
The development of an instrument for measuring Parkinson’s patient empowerment

P. Viwattanakulvanid (Bangkok, Thailand)
The Development of Interactive, Video-Based Modules for Movement Disorders Education

S. Schaefer, L. Vadlamani, P. Juthani (New Haven, CT, USA)
The difference in cerebellar blood flow reduction in multiple system atrophy and Parkinson’s disease

N. Murakami, W. Sako, S. Haji, Y. Izumi, R. Kaji (Tokushima, Japan)
The difference in posture reaction against backward perturbation between patients with Parkinson’s disease and healthy controls

K. Kannari, S. Koseki, C. Narita, S. Sugo. (Aomori, Japan)
The difference of the change of finger surface temperature after short time cold stress test between Parkinson disease and Multiple system atrophy

M. Takahashi, A. Hagiwara, K. Abe, A. Inaba, S. Orimo (Tokyo, Japan)
The distinct cognitive syndromes of Huntington’s disease: A two-year follow-up study

S. Martinez-Horta, F. Sampedro, A. Horta-Barba, J. Perez-Perez, J. Pagonabarraga, J. Marin-Lahoz, H. Bejr-Kasem, I. Aracil, MA. Boti, J. Kulisevsky (Barcelona, Spain)
The effect of age on Substantia Nigra Hyperechogenicity in PD patients and healthy controls

T. Toomsoo, A-H. Pool, I. Liepelt–Scarfone, L. Kadastik-Eerme, I. Rubanovits, T. Asser, D. Berg, P. Taba (Tallinn, Estonia)
The Effect of Conduction Exercise and Self-acupressure in Treatment of Parkinson’s Disease: A Pilot Study

M. Li, K.K. Chua, C.S. Yuen, Z.Y. Zhuang, W.H. Lau, H.Y. Chow (Hong Kong)
The Effect of Short Pulse Width Settings on Speech in Subthalamic Nucleus Deep Brain Stimulation for Parkinson’s disease

V. Dayal, T. Grover, E. Tripoliti, P. Limousin, T. Foltynie (London, United Kingdom)
The Effect of Sleep Deprivation on Short-Term Memory and Emotion of Rotenone Treated Zebrafish Model of Parkinson Disease

Y. Xiong, D. Lv, S. Wei, F. Wang, C. Liu (Suzhou, China)
The effect of thalamic and subthalamic deep brain stimulation on speech in patients with essential tremor: A prospective, randomized, double-blind crossover study

J. Becker, T. Dembek, P. Reker, J. Petry-Schmelzer, D. Mücke, V. Visser-Vandewalle, M. Barbe (Cologne, Germany)
The effectiveness of boxing exercise in elderly patients including Parkinson’s disease patients

N. Kawashima, M. Isogai, M. Matsuhashi, M. Komachi, H. Ikebe, A. Kumon, K. Miyashita, A. Sato, K. Hasegawa (Fujisawa, Japan)
The effectiveness of deep brain stimulation in dystonia: A patient-centered approach

H. Eggink, R. Toonen, J. van Zijl, M. van Egmond, A. Bartels, R. Brandsma, MF. Contarino, K. Peall, J M. van Dijk, DLM. Oterdoom, M. Beudel, M. Tijssen (Groningen, Netherlands)
The effects of bright light therapy on depression, sleep and circadian rhythm in patients with Parkinson’s disease and a depressive disorder: Results of a double-blind randomized controlled trial

S. Rutten, C. Vriend, J. Smit, H. Berendse, E. van Someren, A. Hoogendoorn, J. Twisk, Y. vd Werf, O. vd Heuvel (Amsterdam, Netherlands)
The effects of deep brain stimulation of the pedunculopontine nucleus on cognition in Parkinson’s disease and Progressive Supranuclear Palsy

F. Leimbach, J. Gratwicke, T. Foltynie, M. Hariz, P. Limousin, L. Zrinzo, M. Jahanshahi (London, United Kingdom)
The effects of Nordic walking on gait functions in people with Parkinson’s disease: A long-term pilot study

M. Mak, I. Wong-Yu (Hong Kong, Hong Kong)
The effects of sensory reward cues on risky decision making in Parkinson’s disease

M. Cherkasova, P. Surathi, S. Yeung, AJ. Stoessl, M. McKeown, S. Appel-Cresswell, C. Winstanley, J. Barton (Vancouver, BC, Canada)
The effects of STN-DBS on the Parkinson’s disease patients with different progressive rates

R. Qi, H. Yu, J. Li, X. Geng (Kunming, China)
The effects of treadmill training augmented by virtual reality on postural control and freezing of gait in Parkinson’s disease

E. Bekkers, A. Mirelman, S. Del Din, L. Avanzino, F. Nieuwhof, J. Hausdorff, A. Nieuwboer (Leuven, Belgium)
The efficacy and safety of STN-DBS under general anesthesia for PD patients

W. Chen, L. Chen (Guangzhou, China)
The efficacy of intensive inpatient rehabilitation treatment in Parkinson’s disease patients

J. Shiraishi, T. Okazaki, S. Saeki (Fukuoka, Japan)
The epiphenomenon of movement disorders post-stroke period

J. Shodmonov, B. Muinjanov (Tashkent, Uzbekistan)
The establishment of Deep Brain Stimulation Nurse Association (DBSNA) in United Kingdom (UK)

J. Candelario-Mckeown, L. Partington-Smith, U. Brechany, L. Mooney-Messer, J. Kausar, B. Forrow, S. Perides, L. Nelson (London, United Kingdom)
The etiologies of chronic progressive cerebellar ataxia in a Korean population

J. Youn, M. Kim, JH. AHN, JW. Cho, JS. Kim (Seoul, Republic of Korea)
The first case of Perry syndrome in Estonia

K. Vender, T. Toomsoo, I. Kalju, I. Rubanovits, K. Joost, P. Taba (Tallinn, Estonia)
The FOG score detects relevant changes of gait freezing for patients and experts

U. Fietzek, S. Schulz, K. Ziegler, A. Ceballos-Baumann (Munich, Germany)
The FOsmetpantotenate Replacement Therapy (FORT) Pivotal Trial: Utilization of a Novel Primary Efficacy Outcome in Patients with Pantothenate Kinase-Associated Neurodegeneration

F. Greblikas, M. Escolar, T. Klopstock, R. Marshall, B. Perez, S. Tuller, A. Videnovic (San Diego, CA, USA)
The Gut Microbiota in a Canadian Parkinson’s Disease Cohort

M. Cirstea, E. Golz, B. MacVicar, B. Finlay, S. Cresswell (Vancouver, BC, Canada)
The hardest symptoms that bother patients with Parkinson’s disease before and 3 months after Deep brain stimulation and Continuous infusion of levodopa-carbidopa intestinal therapy

V. Vuletic (Rijeka, Croatia)
The highly selective 5-HT2A receptor antagonist EMD-281,014 alleviates L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson’s disease

I. Frouni, D. Bedard, S. Belliveau, E. Bourgeois-Cayer, A. Hamadjida, P. Huot (Montreal, QC, Canada)
The History of Huntington Disease Description in Russia

D. Labunskiy (Santa Rosa, CA, USA)
The impact of a wearable device on Parkinson’s disease motor symptom management in patients starting rotigotine transdermal patch

S. Isaacson, B. Boroojerdi, K. Klos, S. Carson, M. Markowitz, D. Heldman, M. Phillips, D. Terricabras, F. Woltering, D. Truong (Boca Raton, FL, USA)
The impact of APOε4 polymorphisms and mutations in the GBA gene on the clinical features of Dementia with Lewy Bodies among Ashkenazi Jews

T. Shiner, A. Mirelman, Y. Rozenblum, G. Kave', M. Gana Weisz, A. Bar-Shira, A. Thaler, T. Gurevich, A. Orr-Urtreger, N. Gilad, N. Bregman (Tel Aviv, Israel)
The impact of bilingualism in brain structure and function in early and mild Huntington’s disease

S. Martinez-Horta, A. Moreu, F. Sampedro, J. Perez-Perez, A. Horta-Barba, J. Pagonabarraga, J. Marin-Lahoz, H. Bejr-Kasem, J. Kulisevsky (Barcelona, Spain)
The Impact of short in-patient rehabilitation courses for people with Parkinson´s disease

S. Kinos, K. Martikainen, T. Vahlberg, R. Marttila (Turku, Finland)
The impact of thalamic lesions on visuomotor behavior: A behavioral and fMRI study

M. Wilke, C. Schmidt-Samoa, P. Dechent, K. Miloserdov, J. Liman, M. Holzgraefe, I. Kagan, M. Bähr (Goettingen, Germany)
The Impact of Vocal Fold Augmentation with Injection Laryngoplasty on Voice Quality in Patients with Parkinson Disease

O. Klepitskaya, J. Barr, Y. Liu, S. Sillau, J. Litts, D. Fink, M. Shaffer, J. Newcombe, A. Klepitskaya, M. Clary (Aurora, CO, USA)
The increased α-syn expression inhibits exosomal secretion

Y. Ishiguro, T. Tsunemi, A. Yoroizaka, W. Akamatsu, N. Hattori (Tokyo, Japan)
The independence in daily living activities is the best predictor for quality of life in people with Parkinson’s disease

C. Dionizio, E. Okamoto, C. Miranda, M. d'Alencar, M.E. Piemonte (São Paulo, Brazil)
The Inter-rater Reliability of Parkinson’s Disease Sleep Scale 2 Indonesian Version

R. Buana, R. Pinzon (Yogyakarta, Indonesia)
The Interface of advanced therapies as Parkinson’s disease progresses – case reports

C. Liang, S. Williams, L. Jones, C. Sue, P. Silberstein (St Leonards, Australia)
The international MDSGene initiative: Systematically exploring genotype-phenotype correlations of hereditary movement disorders

S. Petkovic, S. Schaake, J. Huang, H. Madoev, A. Rasheed, C. Lill, K. Lohmann, C. Klein, C. Marras (Lübeck, Germany)
The International Parkinson and Movement Disorder Society Non-Motor Scale (MDS-NMS) for Parkinson’s Disease: Preliminary results from an international validation

K. Ray Chaudhuri, D. Weintraub, A. Rizos, A. Schrag, P. Martinez-Martin (London, United Kingdom)
The Levodopa Response Trial and the Parkinson Disease Digital Biomarker Challenge: Monitoring symptoms of Parkinson’s disease in the lab and home using wearable sensors

J. Daneault, G. Vergara-Diaz, G. Costante, E. Fabara, G. Ferreira-Carvalho, F. Golabchi, F. Parisi, S. Sapienza, Y. Chae, P. Snyder, P. Aubin, P. Banda, D. Brunner, R. Dorsey, L. Mangravite, W. Marks, E. Neto, U. Rubin, E. Soderberg, D. Daeschler, S. Moore, S. Sieberts, L. Omberg, P. Bonato, The Parkinson's Disease Digital Biomarker DREAM Challenge Consortium (Newark, NJ, USA)
The neural effects of a randomized controlled cognitive training program for treating freezing of gait in Parkinson’s disease

M. Gilat, C. Walton, L. Mowszowski, J. Shine, J. Hall, M. Georgiades, A. Muller, C. O'Callaghan, K. Ehgoetz Martens, J. Szeto, S. Naismith, S. Lewis (Sydney, Australia)
The NIC-PD-study –A randomized, placebo-controlled, double-blind, multi-centre trial to assess the disease-modifying potential of transdermal nicotine in early Parkinson‘s disease in Germany and N. America

W. Oertel, H. Müller, C. Schade-Brittinger, C. Kamp, K. Balthasar, K. Articus, M. Brinkman, C. Venuto, M. Unger, K. Eggert, D. Vadasz, K. Kieburtz, J. Boyd (Marburg, Germany)
The nigral hyperintensity on 3 Tesla susceptibility-weighted MRI in patients with vascular parkinsonism

K.J. Kim, Y.J. Bae, J.M. Kim, S.E. Kim, B.S. Jeon (Goyang, Republic of Korea)
The outcome of directional subthalamic deep brain stimulation in advanced Parkinson’s disease

M. Koivu, F. Scheperjans, J. Eerola-Rautio, J. Resendiz-Nieves, J. Marjamaa, R. Kivisaari, E. Pekkonen (Helsinki, Finland)
The Parkinson’s Families Project: A family-based study of early onset and familial Parkinson’s disease

M. Tan, A. Costantini, S. Lubbe, E. Brown, J. Bras, N. Wood, A. Schapira, J. Hardy, H. Morris (London, United Kingdom)
The PDSAFE falls prevention programe for people with Parkinson’s: A multicentre randomised controlled trial

A. Ashburn, R. Pickering, L. Rochester, H. Roberts, C. Ballinger, S. Hulbert, I. Marian, C. Fitton, E. McIntosh, V. Goodwin, A. Nieuwboer, S. Lamb, K. Chivers Seymour (Southampton, United Kingdom)
The phenomenology of visual hallucinations in Parkinson’s disease: A descriptive analysis of Myanmar and Thai patients

Z. Shwe, J. Sringean, E. The, W. Thit, R. Bhidayasiri (Yangon, Myanmar)
The phenotype of ATP1A3+ Rapid-Onset Dystonia-Parkinsonism (RDP) is broader than previously defined

I. Haq, B. Snively, C. Suerken, J. Cook, C. Miller, K. Sweadner, L. Ozelius, C. Whitlow, A. Brashear (Winston Salem, NC, USA)
The Polymorphism of SREBF1 Gene rs11868035 G/A Is Associated with susceptibility to Parkinson’s disease in a Chinese Population

F. Lou, M. Li, XG. Luo, Y. Ren (Shenyang, China)
The Portuguese Version of Montreal Cognitive Assessment as a screening test comparing Vascular Parkinsonism and Parkinson´s Disease in a hospital cross-section study

A. Velon, M. Mendes, R. Almendra, A. Almeida, M. Correia, C. (Vila Real, Portugal)
The possibility of medicamentous correction of the lower urinary tract dysfunction in patients with Parkinson’s disease

M. Tukhtamishev, T. Khodjimetov, F. Akhmedova (Tashkent, Uzbekistan)
The possible neuroprotective potential of galantamine along with soya-lecithin and hydroxychloroquine against ICV-STZ induced cognitive dysfunction in rats

A. Singh, A. Kumar (Patiala, India)
The Predictor Factors on Quality of Life in Patients with Parkinson’s Disease

AD. Wijono, RT. Pinzon (Yogyakarta, Indonesia)
The prevalence and associated features of REM sleep without atonia

F. Dijkstra, M. Viaene, I. de Volder, D. Crosiers, P. Cras (Antwerp, Belgium)
The Prevalence of Dystonic Tremor and Tremor Associated with Dystonia (TAWD) in Patients with Cervical Dystonia

L. Hvizdosova, M. Nevrly, P. Otruba, P. Kanovsky (Olomouc, Czech Republic)
The Prevalence of Gastrointestinal Symptoms in Parkinson’s Disease Patients in Bethesda Hospital, Yogyakarta, Indonesia

A. Al Jody, R. Pinzon (Yogyakarta, Indonesia)
The prevalence of restless legs syndrome in Edirne and its districts concomitant comorbid conditions and secondary complications

S. Güler, A. Caylan, F. Turan (Edirne, Turkey)
The Prevalence of Tandem Gait Abnormality in Parkinson’s Disease

J. Margolesky, S. Bette, D. Shpiner, T. Rundek, C. Luca, H. Moore, C. Singer (Miami, FL, USA)
The pulmonary function and respiratory muscle strength tests of elderly people with Parkinson’s disease: A two-year observational study

R. Gonçalves, J. Neto, P. Cortêz, C. Silva, N. De Souza, E. Souza, T. Freitas, C. Barros, E. Leon, F. Sanchez, E. Andrade (Manaus, Brazil)
The Quality of life in Parkinson’s disease. A follow-up study among 621 Finnish people with Parkinson

K. Martikainen, S. Kinos, T. Vahlberg, R. Marttila (Turku, Finland)
The Quality of Life of the participants in a group singing intervention for people with Parkinson’s: A comparison across China (Beijing), South Korea (Seoul) and Australia (Brisbane)

C. Chang, Y. Irons, E. Han, S. Kim, X. Jiang, D. Stewart (Beijing, China)
The relationship between asymmetric dopamine loss and cognition in early Parkinson’s disease patients from PPMI study

R. Biundo, E. Fiorenzato, L. Weis, A. Antonini (Venice, Italy)
The relationship between family care giver number and progression speed of dementia

Y. Liu, S.L. Yang, Y.C. Wu (Shanghai, China)
The Reliability Study of King’s Parkinson’s Disease Pain Scale in Indonesian Version

V. Wijaya, R. Pinzon (Yogyakarta, Indonesia)
The Research of the Structural Changes of Cerebellar Tissue in Tremor-type Parkinson’s Disease Based on DKI

T. Siyu, T. Dan, X. xiaoyan, Q. Jin, H. Xiushuang (Dalian, China)
The role of deep brain stimulation targeting GPi in patients with multiple system atrophy

P. Hedera, D. Claassen, D. Isaacs (Nashville, TN, USA)
The role of DUODOPA Treatment on Non-Motor Symptoms, Specificly Autonomic Dysfunctions

H. Ekmekci, M. Gültekin, A. Mammadli, Ş. Öztürk (Konya, Turkey)
The role of exposure to pesticides in the etiology of Parkinson’s disease: F-DOPA positron emission tomography study

R. Djaldetti, A. Steinmetz, A. Rigbi, Y. Roditi, L. Greenbaum, M. Lorberboym (Petah Tiqva, Israel)
The role of Genes and Gene x Environment Determinants of Stress in the pathogenesis of Functional Neurological Disorders

P. Spagnolo, C. Maurer, C. Hodgkinson, D. Goldman (Bethesda, MD, USA)
The role of immediate communication by text or phone calls by patients with fluctuation motor complaints in Parkinson’s disease and other movement disorders

A E. Constantino (Clinton, MD, USA)
The role of substantia nigra sonography in the differentiation of Parkinson’s disease and multiple system atrophy

P. Huang, H.Y. Zhou, Y.Y. Tan, S.D. Chen (Shanghai, China)
The scaling properties of chorea and levodopa-induced dyskinesia are similar to voluntary movements

J. Daneault, C. Duval, J. Miranda (Newark, NJ, USA)
The severity of motor symptoms and depression are the higher predictor for the decrease in daily living activities independence in people with Parkinson’s disease

C. Dionizio Dias, E. Okamoto, C. Miranda, M. d'Alencar, M.E. Piemonte (São Paulo, Brazil)
The shared risk of apolipoprotein E ɛ4-allele on hippocampal volume across the spectrum of Alzheimer’s disease and dementia with Lewy bodies: Evidence from the Sunnybrook Dementia Study

U. Saeed, S. Mirza, B. MacIntosh, N. Herrmann, J. Keith, J. Ramirez, S. Nestor, J. Knight, W. Swardfager, E. Rogaeva, E. Black, M. Masellis (Toronto, ON, Canada)
The Small Molecule Alpha-Synuclein Misfolding Inhibitor, NPT200-11, Produces Multiple Benefits in an Animal Model of Parkinson’s Disease

D. Price, M. Koike, W. Wrasidlo, A. Khan, E. Rockenstein, E. Masliah, D. Bonhaus (San Diego, CA, USA)
The spectrum of involuntary movements in patients with motor neuron disease – a cross-sectional study

K. Vogelnik, L. Dolenc Grošelj, B. Koritnik, L. Leonardis, J. Zidar, M. Kojović (Ljubljana, Slovenia)
The study of 18F-FDG PET / CT imaging in the value on Parkinson’s disease

Z. Mao, Z. Xue (Hubei, China)
The subthalamic stimulation inhibit bladder contraction by modulating local field potential and monoamine in the medial prefrontal cortex

T. Yamamoto, R. Sakakibara, T. Uchiyama, S. Kuwabara (Chiba, Japan)
The Timed Up & Go test (time) is inversely associated with fall frequency in progressive supranuclear palsy

N. Matsuda, Y. Takamatsu, I. Aiba (Nagoya, Japan)
The Ultrastructural study of the effects of different types of chronic motor deficit on the morphology of limbic, extrapyramidal and neocortical regions of rat brain

M. Zhvania, N. Lomidze, N. Gogokhia (Tbilisi, Georgia)
The use of a clinical “exercise -immobility test” in a patient with paroxysmal hypnogenic dyskinesia

A. Shalash, A. Abushouk, H. Elrasas (Cairo, Egypt)
The use of DaT scan for diagnosis of Idiopathic Parkinson’s disease and Parkinson’s Plus syndromes in clinical practice (HEFT experience)

M. Awadh, G. Ferris, K. Alam (Birmingham, United Kingdom)
The use of DaT-SPECT scanning in the differential diagnosis of Parkinsonism: Are guidelines being followed?

J. Carling, A. Coldstream, W. Gray, R. Walker (Newcastle upon Tyne, United Kingdom)
The Use of eConsult in a Movement Disorders Clinic

D. Grimes, A. Ohman, C. Liddy, E. Keely, A. Afkhim, T. Mestre (Ottawa, ON, Canada)
The use of gliatilin in the complex treatment of vascular parkinsonism

S. Lukmonov, D. Tolibov (Tashkent, Uzbekistan)
The use of smartphone task derived features to predict clinical scores in Parkinson’s Disease (PD)

C. Lo, S. Arora, F. Baig, T. Barber, M. Lawton, A. Zhan, M. Little, M. Hu (Oxford, United Kingdom)
The Use of Technology-Enabled Care (TEC) in Patients with Parkinson’s Disease: An Italian Survey

C. Di Nuzzo, R. Ferrucci, L. Bertolasi, L. Lo Piano, N. Modugno, M. Onofrj, C. Pacchetti, F. Stocchi, F. Tamma, S. Marceglia, F. Mancini, A. Priori (Milan, Italy)
The usefulness of 18 F-DOPA PET scan in diagnostically challenging patients at a movement disorder clinic

M. Khider, A. Dorutyer, J. Warwick, J. Carr (Cape Town, South Africa)
The utility of electrophysiological tests in the differentiation of upper limb tremor in young-onset patients

P. Panyakaew, R. Bhidayasiri (Bangkok, Thailand)
The validity of the Arabic King’s PD Pain Scale in people with Parkinson’s disease

H. Khalil, A. Al-Sharman, N. Alissa, K. El-Salem, D. Al-Shorofat (Irbid, Jordan)
Therapeutic Drug Monitoring and Pharmacogenetic Tests as Tools in Pharmacovigilance of Anti Parkinson’s Therapy

N. Verma (Baddi, India)
Therapeutic exposures of CX-8998, a potent, selective and state dependent Cav3 channel antagonist in development for Essential Tremor and Parkinson’s disease Tremor in Cav3 driven neurological models

M. Lee, E. Newbold, S. Papapetropoulos (Cambridge, MA, USA)
There’s “still life after Parkinson’s”: A qualitative analysis of the Australian Sing to Beat Parkinson’s® project

D. Stewart, J. Irons, G. Hancox (South Brisbane, Australia)
Three Tesla susceptibility-weighted MR imaging of parkinsonism and idiopathic REM sleep behavior disorder: Comparison with 123I-FP-CIT SPECT

J.M. Kim, Y.J. Bae, Y.S. Song, K.J. Kim, S.E. Kim, B. Jeon (Seongnam-si, Republic of Korea)
Tics in Wilson’s Disease and Review of the Literature

AY. Yılmaz, M. Kuzu Kumcu, MC. Akbostancı (Ankara, Turkey)
Toe dystonia in Parkinson’s disease: Impact of subthalamic nucleus deep brain stimulation

C. Laurencin, S. Montaut, T. Danaila, C. Vial, S. Thobois (Lyon, France)
Total CSF alpha-synuclein is inversely associated with non-motor symptoms in a population of patients with Parkinson’s Disease

T. Schirinzi, G. Sancesario, G. Di Lazzaro, B. Biticchi, N. Mercuri, S. Bernardini, A. Pisani (Rome, Italy)
Toward an automated, video-based method to measure motor severity in cervical dystonia

D. Peterson, Z. Zhang, J. Perlmutter, G. Stebbins, C. Comella (La Jolla, CA, USA)
Toward optimized nonlinear deformation algorithms for subcortical DBS target regions in MRI

S. Ewert, A. Horn, F. Finkel, N. Li, A. Kühn, T. Herrington (Berlin, Germany)
Toxin-induced Parkinsonism: A report of two patients

Z. Aldaajani (Dhahran, Saudi Arabia)
Tracking RBD and PD progression with longitudinal structural brain connectomes

J. Suescun, O. Peña Nogales, T. Ellmore, R. de Luis-Garcia, M. Schiess, L. Giancardo (Houston, TX, USA)
Tractographically defined subthalamic connectivity is associated with apathy in Parkinson’s disease and healthy subjects

N. Vanegas-Arroyave, Y. Gazes, D. Tomishon, A. Boehme (New York, NY, USA)
Traditional Chinese Medicine in treating for salivation and nocturia for patient with Parkinson’s disease

W. Pan, T. Liu, M. Wang, B. Qin (Shanghai, China)
Training in parkinsonism among health providers in Cameroon

M. Kurtis, M. Monje, C. Delgado-Suarez, I. Garcia-Morales, P. Gomez-Iglesias, M. Molina, D. Garcia-Azorin (Madrid, Spain)
Trans-spinal direct current stimulation for managing primary orthostatic tremor

J.C. Lamy, P. Varriale, E. ApartiS, Z. Kosutzka, E. Roze, M. Vidailhet (Paris, France)
Transcranial imaging of substantia nigra hyperechogenicity in a Chinese cohort of Parkinson’s disease

G. Hongling, Y. Qingmei (Wuhan, China)
Transcranial magnetic stimulation increases cognition globally and longitudinally in Parkinson’s disease

J. Trung, A. Hanganu, S. Jobert, C. Degroot, B. Mejia-Constain, M.A. Bruneau, A.L. Lafontaine, Q.P.N. Clinicians, A. Strafella, O. Monchi (Montréal, QC, Canada)
Transcriptional profiling of peripheral blood monocytes from child Friedreich’s ataxia patient: New molecules and patterns of gene expression

H. Singh, V. Swarup, R. Singh, I. Singh, M. Faruq, S. Vivekanandhan, A. Srivastava (Delhi, India)
Transient dystonia of infancy: 25 cases

V. Naranjo, M. Troncoso, A. Barrios, L. Troncoso, S. Witting, S. Lara, D. Muñoz, M. Hidalgo, I. Ruiz (Santiago, Chile)
Transplantation therapy of human iPS cell-derived dopamine neural progenitor cells for Parkinson’s disease

R. Nakamura, G. Oyama, T. Jo, K. Ishikawa, R. Nonaka, Y. Shimo, W. Akamatsu, N. Hattori (Tokyo, Japan)
Treadmill-based gait analysis for gait abnormality of Parkinson disease

C. Shin, T. Ahn (Seoul, Republic of Korea)
Treating Huntington’s Disease using a holistic approach

T. Sinha (Patna, India)
Treatment of Levodopa Dose Failure with Subcutaneous Apomorphine Injection

S. Isaacson (Boca Raton, FL, USA)
Treatment with docosahexaenoic acid in Spinocerebellar Ataxia 38

D. Perani, L. Orsi, C. Costanzi, M. Ferrero, A. Zoppo, F. Tempia, D. Caruso, M. Grassi, A. Padovani, A. Brusco, B. Borroni (Brescia, Italy)
Treatment with levodopa/carbidopa intestinal gel of advanced Parkinson’s disease patients: Bulgarian experience

E. Chorbadzhieva (Sofia, Bulgaria)
TreCap: Quantify and assess tremor in real-time with a new wearable device

R. Bremm, J. Goncalves, K. Koch, F. Hertel (Belvaux, Luxembourg)
Tremor in dystonia: Clinical and electrophysiological assessment in a large series

Z. Jabarkheel, W. Hu, A. Ramirez-Zamora, I. Malaty, W. Deeb, M. Okun, A. Wagle Shukla (Gainesville, FL, USA)
Tremor in motor neuron disease may be central rather than peripheral in origin

A. Latorre, L. Rocchi, M. Stamelou, A. Batla, M. Ciocca, B. Balint, K. Sidle, A. Berardelli, J. Rothwell, K. Bhatia (London, United Kingdom)
Tremor suppression by phase-specific transcranial alternating current stimulation in dystonia and essential tremor

F. Nieuwhof, E. Klimars, I. Toni, B. vande Warrenburg, R. Helmich (Nijmegen, Netherlands)
Trust the Patient not the Doctor: Health-related Quality of Life in Cervical Dystonia

M. Al Hussona, J. Dover, I. Ndukwe, S. O'Riordan, R. Beck, R. Reilly, M. Hutchinson (Dublin, Ireland)
Turkish version of the Johns Hopkins Restless Legs Syndrome Quality of Life Questionnaire (RLS-QoL): Validity and reliability study

S. Güler, N. Turan (Edirne, Turkey)
Turkish version quality of life in essential tremor questionnaire (quest): Validity and reliability study

S. Güler, N. Turan (Edirne, Turkey)
Turning during gait is associated with gray matter density of the nucleus basalis of Meynert in Parkinson’s disease

R. Morris, T. Madhyastha, D. Martini, K. Smulders, J. Quinn, V. Kelly, K. Edwards, C. Zabetian, T. Grabowski, F. Horak (Portland, OR, USA)
Two cases of hemichorea-hemiballism in nonketotic hyperglycemia

S.H. Yi, H.Y. Park (Iksan, Republic of Korea)